L1CAM and cancer: Recently, it has been shown that specific genetic markers [8] (L1 cell adhesion molecule (L1CAM), Anexin 2, insulin-like growth factor receptor, epidermal growth factor receptor, etc.)and aberrant molecular signaling pathways could be key players in cancer cells’ metastatic processes, although further clinical trials are needed to confirm their prognostic value in clinical practice [9].